Rank | Gene Set | Z-score |
---|---|---|
1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.78549550 |
2 | L-phenylalanine catabolic process (GO:0006559) | 6.78549550 |
3 | L-phenylalanine metabolic process (GO:0006558) | 6.40816066 |
4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.40816066 |
5 | regulation of vitamin D biosynthetic process (GO:0060556) | 6.36777262 |
6 | alpha-linolenic acid metabolic process (GO:0036109) | 6.06707415 |
7 | aromatic amino acid family catabolic process (GO:0009074) | 5.89639276 |
8 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.84489771 |
9 | regulation of fever generation (GO:0031620) | 5.31085708 |
10 | bile acid biosynthetic process (GO:0006699) | 5.20816188 |
11 | regulation of vitamin metabolic process (GO:0030656) | 5.19518827 |
12 | sulfur amino acid catabolic process (GO:0000098) | 5.14168358 |
13 | indole-containing compound catabolic process (GO:0042436) | 5.13801318 |
14 | indolalkylamine catabolic process (GO:0046218) | 5.13801318 |
15 | tryptophan catabolic process (GO:0006569) | 5.13801318 |
16 | glyoxylate metabolic process (GO:0046487) | 5.02340290 |
17 | cysteine metabolic process (GO:0006534) | 5.01544876 |
18 | urea metabolic process (GO:0019627) | 5.00534707 |
19 | urea cycle (GO:0000050) | 5.00534707 |
20 | positive regulation of heat generation (GO:0031652) | 4.97769506 |
21 | high-density lipoprotein particle remodeling (GO:0034375) | 4.96275365 |
22 | protein carboxylation (GO:0018214) | 4.95555081 |
23 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.95555081 |
24 | kynurenine metabolic process (GO:0070189) | 4.92460359 |
25 | tryptophan metabolic process (GO:0006568) | 4.89585889 |
26 | negative regulation of fibrinolysis (GO:0051918) | 4.75691966 |
27 | complement activation, alternative pathway (GO:0006957) | 4.74668621 |
28 | tyrosine metabolic process (GO:0006570) | 4.72912608 |
29 | positive regulation of chemokine biosynthetic process (GO:0045080) | 4.69976462 |
30 | plasma lipoprotein particle clearance (GO:0034381) | 4.66219842 |
31 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 4.65345567 |
32 | nitrogen cycle metabolic process (GO:0071941) | 4.56830083 |
33 | bile acid metabolic process (GO:0008206) | 4.56618708 |
34 | regulation of fibrinolysis (GO:0051917) | 4.53188592 |
35 | oligosaccharide catabolic process (GO:0009313) | 4.50335488 |
36 | regulation of protein activation cascade (GO:2000257) | 4.48763333 |
37 | reverse cholesterol transport (GO:0043691) | 4.47442889 |
38 | regulation of triglyceride catabolic process (GO:0010896) | 4.46211589 |
39 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.44165190 |
40 | response to peptidoglycan (GO:0032494) | 4.43932265 |
41 | homocysteine metabolic process (GO:0050667) | 4.43444611 |
42 | aromatic amino acid family metabolic process (GO:0009072) | 4.40671910 |
43 | regulation of cytokine secretion involved in immune response (GO:0002739) | 4.38331199 |
44 | serine family amino acid catabolic process (GO:0009071) | 4.37395413 |
45 | regulation of cholesterol esterification (GO:0010872) | 4.36830879 |
46 | plasma lipoprotein particle remodeling (GO:0034369) | 4.35975994 |
47 | protein-lipid complex remodeling (GO:0034368) | 4.35975994 |
48 | macromolecular complex remodeling (GO:0034367) | 4.35975994 |
49 | triglyceride homeostasis (GO:0070328) | 4.32379942 |
50 | acylglycerol homeostasis (GO:0055090) | 4.32379942 |
51 | cellular glucuronidation (GO:0052695) | 4.26635534 |
52 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.25029276 |
53 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 4.22109583 |
54 | regulation of complement activation (GO:0030449) | 4.18052135 |
55 | negative regulation of interleukin-12 production (GO:0032695) | 4.18005901 |
56 | regulation of chemokine biosynthetic process (GO:0045073) | 4.17917016 |
57 | regulation of mononuclear cell migration (GO:0071675) | 4.15220805 |
58 | regulation of chronic inflammatory response (GO:0002676) | 4.13174177 |
59 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.12399525 |
60 | coenzyme catabolic process (GO:0009109) | 4.09774897 |
61 | regulation of cholesterol homeostasis (GO:2000188) | 4.08794396 |
62 | phospholipid efflux (GO:0033700) | 4.06365755 |
63 | alpha-amino acid catabolic process (GO:1901606) | 4.03808818 |
64 | glycosphingolipid catabolic process (GO:0046479) | 4.02658626 |
65 | acetyl-CoA metabolic process (GO:0006084) | 4.01591181 |
66 | negative regulation of cholesterol transport (GO:0032375) | 4.01467832 |
67 | negative regulation of sterol transport (GO:0032372) | 4.01467832 |
68 | amino-acid betaine metabolic process (GO:0006577) | 4.01147825 |
69 | cholesterol efflux (GO:0033344) | 3.99556535 |
70 | ethanol oxidation (GO:0006069) | 3.97234146 |
71 | regulation of podosome assembly (GO:0071801) | 3.97107529 |
72 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.96134997 |
73 | intestinal cholesterol absorption (GO:0030299) | 3.95424878 |
74 | serine family amino acid biosynthetic process (GO:0009070) | 3.91261913 |
75 | plasma lipoprotein particle assembly (GO:0034377) | 3.90792431 |
76 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.84728352 |
77 | cellular modified amino acid catabolic process (GO:0042219) | 3.84500671 |
78 | glycine metabolic process (GO:0006544) | 3.83508533 |
79 | regulation of heat generation (GO:0031650) | 3.81484545 |
80 | glucuronate metabolic process (GO:0019585) | 3.81374263 |
81 | uronic acid metabolic process (GO:0006063) | 3.81374263 |
82 | bile acid and bile salt transport (GO:0015721) | 3.81232402 |
83 | serine family amino acid metabolic process (GO:0009069) | 3.80359367 |
84 | positive regulation of lipid catabolic process (GO:0050996) | 3.80299749 |
85 | cellular amino acid catabolic process (GO:0009063) | 3.79072523 |
86 | low-density lipoprotein particle clearance (GO:0034383) | 3.78909842 |
87 | lysine metabolic process (GO:0006553) | 3.78776751 |
88 | lysine catabolic process (GO:0006554) | 3.78776751 |
89 | cellular ketone body metabolic process (GO:0046950) | 3.75693676 |
90 | phospholipid homeostasis (GO:0055091) | 3.75414778 |
91 | low-density lipoprotein particle remodeling (GO:0034374) | 3.74660180 |
92 | indolalkylamine metabolic process (GO:0006586) | 3.73643051 |
93 | activation of MAPKKK activity (GO:0000185) | 3.72321076 |
94 | amine catabolic process (GO:0009310) | 3.69692927 |
95 | cellular biogenic amine catabolic process (GO:0042402) | 3.69692927 |
96 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.68122031 |
97 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.67541884 |
98 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.64987315 |
99 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.64145592 |
100 | regulation of cholesterol metabolic process (GO:0090181) | 3.63592887 |
101 | glycolipid catabolic process (GO:0019377) | 3.63456434 |
102 | linoleic acid metabolic process (GO:0043651) | 3.63104844 |
103 | glutamate metabolic process (GO:0006536) | 3.59627077 |
104 | short-chain fatty acid metabolic process (GO:0046459) | 3.56033759 |
105 | cholesterol homeostasis (GO:0042632) | 3.55653210 |
106 | plasma lipoprotein particle organization (GO:0071827) | 3.55466431 |
107 | NIK/NF-kappaB signaling (GO:0038061) | 3.55356817 |
108 | imidazole-containing compound metabolic process (GO:0052803) | 3.55195355 |
109 | protein-lipid complex assembly (GO:0065005) | 3.55102533 |
110 | benzene-containing compound metabolic process (GO:0042537) | 3.54280901 |
111 | response to nitrosative stress (GO:0051409) | 3.53568674 |
112 | sterol homeostasis (GO:0055092) | 3.51399318 |
113 | fibrinolysis (GO:0042730) | 3.48903033 |
114 | regulation of cholesterol storage (GO:0010885) | 3.48426729 |
115 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.48132718 |
116 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.48126492 |
117 | lipoprotein metabolic process (GO:0042157) | 3.48051100 |
118 | cofactor catabolic process (GO:0051187) | 3.47825245 |
119 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.47289482 |
120 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.47289482 |
121 | ketone body metabolic process (GO:1902224) | 3.46154752 |
122 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.45666898 |
123 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.45463789 |
124 | organic acid catabolic process (GO:0016054) | 3.42039614 |
125 | carboxylic acid catabolic process (GO:0046395) | 3.42039614 |
126 | very long-chain fatty acid metabolic process (GO:0000038) | 3.40761396 |
127 | * cholesterol biosynthetic process (GO:0006695) | 3.39474489 |
128 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 3.37316976 |
129 | monocyte chemotaxis (GO:0002548) | 3.33132196 |
130 | cellular response to arsenic-containing substance (GO:0071243) | 3.33085442 |
131 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 3.28721127 |
132 | regulation of interferon-alpha production (GO:0032647) | 3.27756345 |
133 | regulation of nitric oxide biosynthetic process (GO:0045428) | 3.27120176 |
134 | negative regulation of lipid storage (GO:0010888) | 3.26674064 |
135 | myeloid dendritic cell differentiation (GO:0043011) | 3.23946550 |
136 | cellular response to lipopolysaccharide (GO:0071222) | 3.22521144 |
137 | regulation of immunoglobulin secretion (GO:0051023) | 3.21082744 |
138 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 3.15024138 |
139 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.13975543 |
140 | T-helper 1 type immune response (GO:0042088) | 3.12178726 |
141 | macrophage activation involved in immune response (GO:0002281) | 3.11053508 |
142 | ceramide catabolic process (GO:0046514) | 3.10601288 |
143 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.07368336 |
144 | germinal center formation (GO:0002467) | 3.06375062 |
145 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.05990879 |
146 | cellular response to molecule of bacterial origin (GO:0071219) | 3.05723545 |
147 | cellular response to nicotine (GO:0071316) | 3.05150147 |
148 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.04942966 |
149 | response to thyroid hormone (GO:0097066) | 3.04795591 |
150 | positive regulation of lipid storage (GO:0010884) | 3.01969671 |
151 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.97280149 |
152 | membrane lipid catabolic process (GO:0046466) | 2.95734963 |
153 | positive regulation of acute inflammatory response (GO:0002675) | 2.95146254 |
154 | positive regulation of interleukin-6 production (GO:0032755) | 2.93736297 |
155 | adhesion of symbiont to host (GO:0044406) | 2.92313540 |
156 | virion attachment to host cell (GO:0019062) | 2.92207666 |
157 | adhesion of symbiont to host cell (GO:0044650) | 2.92207666 |
158 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.90474034 |
159 | lipid storage (GO:0019915) | 2.89642853 |
160 | cellular response to type I interferon (GO:0071357) | 2.79015007 |
161 | type I interferon signaling pathway (GO:0060337) | 2.79015007 |
162 | sphingolipid catabolic process (GO:0030149) | 2.78273702 |
163 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.77428709 |
164 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.77117342 |
165 | response to protozoan (GO:0001562) | 2.75369022 |
166 | response to type I interferon (GO:0034340) | 2.74751451 |
167 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.73331339 |
168 | response to muramyl dipeptide (GO:0032495) | 2.73181154 |
169 | cellular response to biotic stimulus (GO:0071216) | 2.68027293 |
170 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.68016847 |
171 | regulation of NF-kappaB import into nucleus (GO:0042345) | 2.67119168 |
172 | myeloid dendritic cell activation (GO:0001773) | 2.66016742 |
173 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.63568210 |
174 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.63355756 |
175 | acute-phase response (GO:0006953) | 2.63210721 |
176 | positive regulation of extracellular matrix organization (GO:1903055) | 2.62310677 |
177 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.62009476 |
178 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.61600308 |
179 | positive regulation of p38MAPK cascade (GO:1900745) | 2.59600715 |
180 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.59521247 |
181 | regulation of growth of symbiont in host (GO:0044126) | 2.59521247 |
182 | negative regulation of growth of symbiont in host (GO:0044130) | 2.59521247 |
183 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.59521247 |
184 | regulation of lipid storage (GO:0010883) | 2.57848296 |
185 | positive regulation of interferon-alpha production (GO:0032727) | 2.56738823 |
186 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.56483607 |
187 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.56184491 |
188 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.55306304 |
189 | protein localization to endosome (GO:0036010) | 2.54601508 |
190 | neutrophil activation involved in immune response (GO:0002283) | 2.53520794 |
191 | detection of molecule of bacterial origin (GO:0032490) | 2.51031474 |
192 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.48648773 |
193 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.48425250 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.71267740 |
2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.51750940 |
3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.19216936 |
4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.18906576 |
5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.81855277 |
6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.99784066 |
7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.66659159 |
8 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 4.34816436 |
9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.72629251 |
10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.59580671 |
11 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.58838247 |
12 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.07052861 |
13 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.75201439 |
14 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.72459789 |
15 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.67129446 |
16 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.36094667 |
17 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.29114985 |
18 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.13319532 |
19 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.09991006 |
20 | * VDR_21846776_ChIP-Seq_THP-1_Human | 2.09258633 |
21 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.6886361 |
22 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.93820235 |
23 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.86795242 |
24 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.85651814 |
25 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.84862073 |
26 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.81285745 |
27 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.75023838 |
28 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.71572206 |
29 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.70760036 |
30 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.67495569 |
31 | MYC_22102868_ChIP-Seq_BL_Human | 1.67367296 |
32 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.60285688 |
33 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.59871092 |
34 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.59355181 |
35 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.59210556 |
36 | SPI1_23127762_ChIP-Seq_K562_Human | 1.49102042 |
37 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.47444252 |
38 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.46804909 |
39 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.46188404 |
40 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.42526739 |
41 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.42108146 |
42 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.39513331 |
43 | MAF_26560356_Chip-Seq_TH1_Human | 1.39498188 |
44 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.38817969 |
45 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.37405363 |
46 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.36097960 |
47 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.35831541 |
48 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.35534002 |
49 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.34666400 |
50 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.34011204 |
51 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.33967991 |
52 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.33830198 |
53 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.33201899 |
54 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.31537163 |
55 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.29742037 |
56 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.28767762 |
57 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.27997615 |
58 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.27744183 |
59 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24744222 |
60 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.24438454 |
61 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.24438454 |
62 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.23597468 |
63 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.23132757 |
64 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.22060157 |
65 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.19097685 |
66 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.18642043 |
67 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.17678681 |
68 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.16933028 |
69 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.14372226 |
70 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.14089430 |
71 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.13999237 |
72 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.12319946 |
73 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.12319946 |
74 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.12319946 |
75 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.12285677 |
76 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.11854337 |
77 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.10222303 |
78 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.06472156 |
79 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05787294 |
80 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.04036343 |
81 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.02861806 |
82 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.02018827 |
83 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.01746849 |
84 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.00998381 |
85 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.99787169 |
86 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.98835723 |
87 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.98770818 |
88 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.98562657 |
89 | * KDM2B_26808549_Chip-Seq_K562_Human | 0.98558167 |
90 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.98454136 |
91 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.96680901 |
92 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.96651700 |
93 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.96631633 |
94 | * SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.96024613 |
95 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.95967549 |
96 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95268730 |
97 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.94970424 |
98 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94906291 |
99 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.94608685 |
100 | GATA1_22025678_ChIP-Seq_K562_Human | 0.94600442 |
101 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.92736891 |
102 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.91966252 |
103 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.91906636 |
104 | * UTX_26944678_Chip-Seq_JUKART_Human | 0.91311377 |
105 | MAF_26560356_Chip-Seq_TH2_Human | 0.91024518 |
106 | MYB_26560356_Chip-Seq_TH1_Human | 0.90237784 |
107 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.89825498 |
108 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89494849 |
109 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.86550742 |
110 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.83934810 |
111 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.83665184 |
112 | * TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.83472572 |
113 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.82194661 |
114 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.81155625 |
115 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.80578868 |
116 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.79915017 |
117 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.78352627 |
118 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.76971061 |
119 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.75813089 |
120 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.74888499 |
121 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.73744624 |
122 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.73203038 |
123 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.73168430 |
124 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.72533166 |
125 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.71225001 |
126 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.71191655 |
127 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.70160488 |
128 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.68535836 |
129 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.67347137 |
130 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.66171234 |
131 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.64986130 |
132 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.62873245 |
133 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.62154476 |
134 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.61847521 |
135 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.61845617 |
136 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.61188362 |
137 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.60504690 |
138 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.57408892 |
139 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.57068118 |
140 | CJUN_26792858_Chip-Seq_BT549_Human | 0.56424401 |
141 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.55571880 |
142 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.54904076 |
143 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.53133287 |
144 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.53090087 |
145 | CBP_21632823_ChIP-Seq_H3396_Human | 0.52938596 |
146 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.51557957 |
147 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.51294866 |
148 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.50339993 |
149 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.49088743 |
150 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.46805987 |
151 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.45567320 |
152 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.45363214 |
153 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.44685199 |
154 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.44628905 |
155 | GATA2_19941826_ChIP-Seq_K562_Human | 0.44023588 |
156 | * GATA1_19941826_ChIP-Seq_K562_Human | 0.42916018 |
157 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.42144201 |
158 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.41889077 |
159 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.41873756 |
160 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.41859720 |
161 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.41692206 |
162 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.40859682 |
163 | AR_20517297_ChIP-Seq_VCAP_Human | 0.40088282 |
164 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.39944520 |
165 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.39814637 |
166 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.39531331 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * MP0002139_abnormal_hepatobiliary_system | 7.41309515 |
2 | MP0005360_urolithiasis | 6.72361551 |
3 | MP0005085_abnormal_gallbladder_physiolo | 5.74982130 |
4 | MP0005365_abnormal_bile_salt | 5.72584509 |
5 | MP0003303_peritoneal_inflammation | 5.53203517 |
6 | MP0008875_abnormal_xenobiotic_pharmacok | 4.30498025 |
7 | MP0003806_abnormal_nucleotide_metabolis | 3.88858355 |
8 | MP0009840_abnormal_foam_cell | 3.74402697 |
9 | MP0010329_abnormal_lipoprotein_level | 3.64140319 |
10 | MP0003252_abnormal_bile_duct | 3.41358347 |
11 | MP0005083_abnormal_biliary_tract | 3.38289229 |
12 | MP0006082_CNS_inflammation | 3.07218066 |
13 | MP0002148_abnormal_hypersensitivity_rea | 2.95360118 |
14 | MP0004510_myositis | 2.89180676 |
15 | MP0009785_altered_susceptibility_to | 2.85555266 |
16 | MP0003195_calcinosis | 2.85321685 |
17 | MP0005332_abnormal_amino_acid | 2.49498947 |
18 | MP0001666_abnormal_nutrient_absorption | 2.47183745 |
19 | MP0000343_altered_response_to | 2.34459391 |
20 | * MP0002118_abnormal_lipid_homeostasis | 2.31052099 |
21 | MP0005000_abnormal_immune_tolerance | 2.24311319 |
22 | * MP0000609_abnormal_liver_physiology | 2.21551651 |
23 | MP0003191_abnormal_cellular_cholesterol | 2.20144243 |
24 | MP0004947_skin_inflammation | 2.14566870 |
25 | MP0002419_abnormal_innate_immunity | 2.09699340 |
26 | MP0003868_abnormal_feces_composition | 1.96158252 |
27 | MP0001790_abnormal_immune_system | 1.93746011 |
28 | MP0005387_immune_system_phenotype | 1.93746011 |
29 | MP0001835_abnormal_antigen_presentation | 1.86934263 |
30 | MP0003172_abnormal_lysosome_physiology | 1.86360705 |
31 | MP0005025_abnormal_response_to | 1.85386082 |
32 | MP0008004_abnormal_stomach_pH | 1.85025126 |
33 | MP0001853_heart_inflammation | 1.78452410 |
34 | MP0003705_abnormal_hypodermis_morpholog | 1.78140800 |
35 | MP0009278_abnormal_bone_marrow | 1.76833732 |
36 | MP0001545_abnormal_hematopoietic_system | 1.72782349 |
37 | MP0005397_hematopoietic_system_phenotyp | 1.72782349 |
38 | MP0004019_abnormal_vitamin_homeostasis | 1.72729597 |
39 | MP0005671_abnormal_response_to | 1.70576980 |
40 | MP0002452_abnormal_antigen_presenting | 1.64562972 |
41 | MP0002332_abnormal_exercise_endurance | 1.64100126 |
42 | MP0002723_abnormal_immune_serum | 1.61655111 |
43 | MP0005319_abnormal_enzyme/_coenzyme | 1.61570665 |
44 | MP0003186_abnormal_redox_activity | 1.55255104 |
45 | MP0003011_delayed_dark_adaptation | 1.52977912 |
46 | MP0001845_abnormal_inflammatory_respons | 1.49847641 |
47 | MP0005408_hypopigmentation | 1.48710802 |
48 | MP0005670_abnormal_white_adipose | 1.47341404 |
49 | MP0005167_abnormal_blood-brain_barrier | 1.47171694 |
50 | MP0001764_abnormal_homeostasis | 1.46571228 |
51 | MP0001800_abnormal_humoral_immune | 1.45218908 |
52 | MP0002138_abnormal_hepatobiliary_system | 1.45079874 |
53 | MP0003448_altered_tumor_morphology | 1.44297510 |
54 | MP0000858_altered_metastatic_potential | 1.42442123 |
55 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.42023379 |
56 | MP0002998_abnormal_bone_remodeling | 1.39912785 |
57 | MP0009333_abnormal_splenocyte_physiolog | 1.38038293 |
58 | MP0009697_abnormal_copulation | 1.35727298 |
59 | MP0010155_abnormal_intestine_physiology | 1.35289239 |
60 | MP0005166_decreased_susceptibility_to | 1.29703370 |
61 | MP0008438_abnormal_cutaneous_collagen | 1.28863721 |
62 | MP0006054_spinal_hemorrhage | 1.25801602 |
63 | MP0002420_abnormal_adaptive_immunity | 1.23214592 |
64 | MP0001819_abnormal_immune_cell | 1.23013178 |
65 | MP0002405_respiratory_system_inflammati | 1.20178122 |
66 | MP0004130_abnormal_muscle_cell | 1.19622012 |
67 | MP0005310_abnormal_salivary_gland | 1.18367579 |
68 | MP0000604_amyloidosis | 1.17969992 |
69 | MP0005220_abnormal_exocrine_pancreas | 1.17222063 |
70 | * MP0000598_abnormal_liver_morphology | 1.16702707 |
71 | MP0002971_abnormal_brown_adipose | 1.16371661 |
72 | MP0000685_abnormal_immune_system | 1.16095394 |
73 | MP0005666_abnormal_adipose_tissue | 1.15342486 |
74 | MP0002254_reproductive_system_inflammat | 1.13130344 |
75 | MP0005647_abnormal_sex_gland | 1.13029079 |
76 | MP0003690_abnormal_glial_cell | 1.12855202 |
77 | MP0009643_abnormal_urine_homeostasis | 1.08242712 |
78 | MP0010307_abnormal_tumor_latency | 1.07518845 |
79 | MP0003656_abnormal_erythrocyte_physiolo | 1.06506887 |
80 | MP0005334_abnormal_fat_pad | 1.05478771 |
81 | MP0005451_abnormal_body_composition | 1.02154188 |
82 | MP0002876_abnormal_thyroid_physiology | 1.01878669 |
83 | MP0005076_abnormal_cell_differentiation | 1.01267574 |
84 | MP0009763_increased_sensitivity_to | 1.00456527 |
85 | MP0002078_abnormal_glucose_homeostasis | 0.98573131 |
86 | MP0003091_abnormal_cell_migration | 0.97753560 |
87 | MP0002877_abnormal_melanocyte_morpholog | 0.95982403 |
88 | MP0010352_gastrointestinal_tract_polyps | 0.93637056 |
89 | MP0004185_abnormal_adipocyte_glucose | 0.93630506 |
90 | MP0000920_abnormal_myelination | 0.93024565 |
91 | MP0003221_abnormal_cardiomyocyte_apopto | 0.90602832 |
92 | MP0000716_abnormal_immune_system | 0.89938720 |
93 | MP0009764_decreased_sensitivity_to | 0.85969926 |
94 | MP0003950_abnormal_plasma_membrane | 0.85732904 |
95 | MP0001661_extended_life_span | 0.84017585 |
96 | MP0004808_abnormal_hematopoietic_stem | 0.81213690 |
97 | MP0005248_abnormal_Harderian_gland | 0.80843075 |
98 | MP0003329_amyloid_beta_deposits | 0.80189943 |
99 | MP0005535_abnormal_body_temperature | 0.80000534 |
100 | * MP0009642_abnormal_blood_homeostasis | 0.79860875 |
101 | MP0008874_decreased_physiological_sensi | 0.77764548 |
102 | MP0002398_abnormal_bone_marrow | 0.77649686 |
103 | MP0009765_abnormal_xenobiotic_induced | 0.77229970 |
104 | MP0005448_abnormal_energy_balance | 0.76971155 |
105 | MP0003724_increased_susceptibility_to | 0.76792192 |
106 | MP0005165_increased_susceptibility_to | 0.76466518 |
107 | MP0008260_abnormal_autophagy | 0.75772616 |
108 | MP0008469_abnormal_protein_level | 0.75725993 |
109 | MP0001727_abnormal_embryo_implantation | 0.75558813 |
110 | MP0004782_abnormal_surfactant_physiolog | 0.75537505 |
111 | MP0001881_abnormal_mammary_gland | 0.75146732 |
112 | MP0002429_abnormal_blood_cell | 0.72846254 |
113 | MP0003718_maternal_effect | 0.72842531 |
114 | MP0005058_abnormal_lysosome_morphology | 0.71517868 |
115 | MP0005023_abnormal_wound_healing | 0.71206822 |
116 | MP0000689_abnormal_spleen_morphology | 0.70549294 |
117 | MP0005395_other_phenotype | 0.69794788 |
118 | MP0005376_homeostasis/metabolism_phenot | 0.68987707 |
119 | MP0000639_abnormal_adrenal_gland | 0.68342954 |
120 | MP0002722_abnormal_immune_system | 0.67113597 |
121 | MP0001542_abnormal_bone_strength | 0.66892821 |
122 | MP0005084_abnormal_gallbladder_morpholo | 0.66082115 |
123 | MP0009115_abnormal_fat_cell | 0.62365308 |
124 | MP0003436_decreased_susceptibility_to | 0.61459770 |
125 | MP0009384_cardiac_valve_regurgitation | 0.60119365 |
126 | MP0002970_abnormal_white_adipose | 0.60072417 |
127 | MP0005375_adipose_tissue_phenotype | 0.58732179 |
128 | MP0005636_abnormal_mineral_homeostasis | 0.56607750 |
129 | MP0001243_abnormal_dermal_layer | 0.54888084 |
130 | MP0010368_abnormal_lymphatic_system | 0.53495224 |
131 | MP0003953_abnormal_hormone_level | 0.52585821 |
132 | MP0009053_abnormal_anal_canal | 0.51829310 |
133 | MP0002168_other_aberrant_phenotype | 0.51239120 |
134 | MP0000647_abnormal_sebaceous_gland | 0.51069170 |
135 | MP0004381_abnormal_hair_follicle | 0.50945082 |
136 | MP0003959_abnormal_lean_body | 0.50490038 |
137 | MP0009672_abnormal_birth_weight | 0.50443667 |
138 | MP0001177_atelectasis | 0.50127633 |
139 | MP0002060_abnormal_skin_morphology | 0.49752977 |
140 | MP0000427_abnormal_hair_cycle | 0.48728010 |
141 | MP0003300_gastrointestinal_ulcer | 0.48684070 |
142 | MP0001756_abnormal_urination | 0.48169263 |
143 | MP0001944_abnormal_pancreas_morphology | 0.47699688 |
144 | MP0005164_abnormal_response_to | 0.47493654 |
145 | MP0002090_abnormal_vision | 0.45715780 |
146 | MP0009780_abnormal_chondrocyte_physiolo | 0.44774807 |
147 | MP0005266_abnormal_metabolism | 0.44525355 |
148 | MP0000371_diluted_coat_color | 0.44419005 |
149 | MP0001324_abnormal_eye_pigmentation | 0.44193161 |
150 | MP0003453_abnormal_keratinocyte_physiol | 0.42790833 |
151 | MP0006036_abnormal_mitochondrial_physio | 0.41659109 |
152 | MP0003075_altered_response_to | 0.39956268 |
153 | MP0001533_abnormal_skeleton_physiology | 0.39298536 |
154 | MP0005464_abnormal_platelet_physiology | 0.39269076 |
155 | MP0000372_irregular_coat_pigmentation | 0.38962053 |
156 | MP0002295_abnormal_pulmonary_circulatio | 0.36774501 |
157 | MP0008873_increased_physiological_sensi | 0.35332707 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of glycolipid metabolism (HP:0010969) | 7.06804354 |
2 | Abnormality of liposaccharide metabolism (HP:0010968) | 7.06804354 |
3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 7.06804354 |
4 | Intrahepatic cholestasis (HP:0001406) | 7.02440585 |
5 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.69190406 |
6 | Deep venous thrombosis (HP:0002625) | 6.55687291 |
7 | Xanthomatosis (HP:0000991) | 6.44244491 |
8 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.84242650 |
9 | Prolonged partial thromboplastin time (HP:0003645) | 5.69748029 |
10 | Hypobetalipoproteinemia (HP:0003563) | 5.62936745 |
11 | Vacuolated lymphocytes (HP:0001922) | 5.49941531 |
12 | Hyperlipoproteinemia (HP:0010980) | 5.20043207 |
13 | Epidermoid cyst (HP:0200040) | 5.15192177 |
14 | Complement deficiency (HP:0004431) | 4.66057290 |
15 | Hypolipoproteinemia (HP:0010981) | 4.63079696 |
16 | Dysostosis multiplex (HP:0000943) | 4.48519314 |
17 | Loss of speech (HP:0002371) | 4.46411034 |
18 | Increased cerebral lipofuscin (HP:0011813) | 4.38097178 |
19 | Hypoalphalipoproteinemia (HP:0003233) | 4.35343054 |
20 | Hyperglycinemia (HP:0002154) | 4.29263900 |
21 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.29164819 |
22 | Disinhibition (HP:0000734) | 4.20225695 |
23 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.15277899 |
24 | Joint hemorrhage (HP:0005261) | 4.15135307 |
25 | Hyperammonemia (HP:0001987) | 4.11661408 |
26 | Abnormality of the common coagulation pathway (HP:0010990) | 4.10643359 |
27 | Hyperglycinuria (HP:0003108) | 4.08534143 |
28 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.07130656 |
29 | Abnormality of glycine metabolism (HP:0010895) | 4.07130656 |
30 | Abnormality of macrophages (HP:0004311) | 4.04750195 |
31 | Hypoglycemic coma (HP:0001325) | 4.04064136 |
32 | Fat malabsorption (HP:0002630) | 4.01989046 |
33 | Abnormality of methionine metabolism (HP:0010901) | 3.91531237 |
34 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.89534635 |
35 | Ketosis (HP:0001946) | 3.89141048 |
36 | Nuclear cataract (HP:0100018) | 3.84240892 |
37 | Myocardial infarction (HP:0001658) | 3.76739951 |
38 | Abnormality of the intrinsic pathway (HP:0010989) | 3.70186513 |
39 | Neurofibrillary tangles (HP:0002185) | 3.68507218 |
40 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.68123627 |
41 | Hypercholesterolemia (HP:0003124) | 3.60843158 |
42 | Abnormality of complement system (HP:0005339) | 3.55571569 |
43 | Mutism (HP:0002300) | 3.53451266 |
44 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.43560178 |
45 | Conjugated hyperbilirubinemia (HP:0002908) | 3.41903805 |
46 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.34066360 |
47 | Skin nodule (HP:0200036) | 3.20090289 |
48 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.19760916 |
49 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.19760916 |
50 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.19760916 |
51 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.15416901 |
52 | Autoimmune thrombocytopenia (HP:0001973) | 3.14899859 |
53 | Optic neuritis (HP:0100653) | 3.09890797 |
54 | Retrobulbar optic neuritis (HP:0100654) | 3.09890797 |
55 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.09068772 |
56 | Mucopolysacchariduria (HP:0008155) | 3.09068772 |
57 | Increased serum ferritin (HP:0003281) | 3.07883769 |
58 | Steatorrhea (HP:0002570) | 3.07759445 |
59 | Axonal loss (HP:0003447) | 3.04165466 |
60 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.03183532 |
61 | Cerebral inclusion bodies (HP:0100314) | 3.00932739 |
62 | Orchitis (HP:0100796) | 3.00658218 |
63 | Ketoacidosis (HP:0001993) | 3.00229675 |
64 | Cholecystitis (HP:0001082) | 2.99483066 |
65 | Abnormal gallbladder physiology (HP:0012438) | 2.99483066 |
66 | Hypoglycemic seizures (HP:0002173) | 2.95357211 |
67 | Hyperbilirubinemia (HP:0002904) | 2.88040769 |
68 | Abnormality of serum amino acid levels (HP:0003112) | 2.86240076 |
69 | Hepatocellular carcinoma (HP:0001402) | 2.83867371 |
70 | Nausea (HP:0002018) | 2.83549909 |
71 | Apathy (HP:0000741) | 2.79608658 |
72 | Neuronal loss in central nervous system (HP:0002529) | 2.77401509 |
73 | Diminished motivation (HP:0000745) | 2.72382754 |
74 | Abnormality of proline metabolism (HP:0010907) | 2.69704917 |
75 | Hydroxyprolinuria (HP:0003080) | 2.69704917 |
76 | Recurrent bacterial skin infections (HP:0005406) | 2.68344194 |
77 | Acanthocytosis (HP:0001927) | 2.67558823 |
78 | Abnormality of nucleobase metabolism (HP:0010932) | 2.64724745 |
79 | Mediastinal lymphadenopathy (HP:0100721) | 2.60303886 |
80 | Recurrent abscess formation (HP:0002722) | 2.56506105 |
81 | Purpura (HP:0000979) | 2.54287315 |
82 | Delayed CNS myelination (HP:0002188) | 2.50579260 |
83 | Stomatitis (HP:0010280) | 2.46488598 |
84 | Abnormality of purine metabolism (HP:0004352) | 2.45495352 |
85 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.42768020 |
86 | Tetraparesis (HP:0002273) | 2.42718705 |
87 | Spontaneous abortion (HP:0005268) | 2.41953979 |
88 | Hepatosplenomegaly (HP:0001433) | 2.41001678 |
89 | Upper motor neuron abnormality (HP:0002127) | 2.40769725 |
90 | Eczematoid dermatitis (HP:0000976) | 2.39566744 |
91 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.39548618 |
92 | Mitral stenosis (HP:0001718) | 2.38379662 |
93 | Progressive neurologic deterioration (HP:0002344) | 2.37166362 |
94 | Abnormality of iron homeostasis (HP:0011031) | 2.36146392 |
95 | Abnormal cartilage morphology (HP:0002763) | 2.33626344 |
96 | Prolonged neonatal jaundice (HP:0006579) | 2.33294217 |
97 | Vascular calcification (HP:0004934) | 2.33188548 |
98 | Irritability (HP:0000737) | 2.33180305 |
99 | Myositis (HP:0100614) | 2.31674467 |
100 | Pancreatitis (HP:0001733) | 2.31472066 |
101 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.27365629 |
102 | Keratoconjunctivitis sicca (HP:0001097) | 2.26439811 |
103 | Gangrene (HP:0100758) | 2.26074625 |
104 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.24570385 |
105 | Parakeratosis (HP:0001036) | 2.23328239 |
106 | Systemic lupus erythematosus (HP:0002725) | 2.21651326 |
107 | Vertebral compression fractures (HP:0002953) | 2.20529134 |
108 | Metabolic acidosis (HP:0001942) | 2.19316427 |
109 | Dicarboxylic aciduria (HP:0003215) | 2.18930352 |
110 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.18930352 |
111 | Esophageal varix (HP:0002040) | 2.18538175 |
112 | Hypochromic microcytic anemia (HP:0004840) | 2.18073313 |
113 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.18035815 |
114 | Spastic diplegia (HP:0001264) | 2.17695672 |
115 | Hyperglycemia (HP:0003074) | 2.17640139 |
116 | Abnormal gallbladder morphology (HP:0012437) | 2.15943381 |
117 | Protuberant abdomen (HP:0001538) | 2.14824761 |
118 | Cardiovascular calcification (HP:0011915) | 2.14446143 |
119 | Turricephaly (HP:0000262) | 2.12273180 |
120 | Amyloidosis (HP:0011034) | 2.12248512 |
121 | Lethargy (HP:0001254) | 2.09735367 |
122 | Inappropriate behavior (HP:0000719) | 2.09227118 |
123 | Metaphyseal irregularity (HP:0003025) | 2.08153615 |
124 | Cortical dysplasia (HP:0002539) | 2.07844059 |
125 | Late onset (HP:0003584) | 2.07029217 |
126 | Brushfield spots (HP:0001088) | 2.06556785 |
127 | Personality changes (HP:0000751) | 2.05038037 |
128 | Generalized aminoaciduria (HP:0002909) | 2.03535754 |
129 | Peripheral demyelination (HP:0011096) | 2.03533475 |
130 | Hemorrhage of the eye (HP:0011885) | 2.02155157 |
131 | Symptomatic seizures (HP:0011145) | 2.00657635 |
132 | Bone pain (HP:0002653) | 2.00640641 |
133 | Gingival bleeding (HP:0000225) | 2.00481383 |
134 | Cardiomegaly (HP:0001640) | 1.99608974 |
135 | Hypophosphatemic rickets (HP:0004912) | 1.99064262 |
136 | Glomerulonephritis (HP:0000099) | 1.98213773 |
137 | Interstitial pulmonary disease (HP:0006530) | 1.98072140 |
138 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.97547159 |
139 | Rickets (HP:0002748) | 1.97351606 |
140 | Polycythemia (HP:0001901) | 1.96852806 |
141 | Agnosia (HP:0010524) | 1.96148399 |
142 | Sensorimotor neuropathy (HP:0007141) | 1.96039671 |
143 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.95185197 |
144 | Keratoconjunctivitis (HP:0001096) | 1.94759663 |
145 | Hypertriglyceridemia (HP:0002155) | 1.94593181 |
146 | Autoimmune hemolytic anemia (HP:0001890) | 1.89570892 |
147 | Abnormal tarsal ossification (HP:0008369) | 1.87992349 |
148 | Pathologic fracture (HP:0002756) | 1.86311781 |
149 | Petechiae (HP:0000967) | 1.86281822 |
150 | Epiphyseal stippling (HP:0010655) | 1.86225996 |
151 | Recurrent viral infections (HP:0004429) | 1.86143238 |
152 | Thoracic kyphosis (HP:0002942) | 1.86108894 |
153 | J-shaped sella turcica (HP:0002680) | 1.86044745 |
154 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.85220232 |
155 | Elevated alkaline phosphatase (HP:0003155) | 1.84928382 |
156 | Supranuclear gaze palsy (HP:0000605) | 1.84466472 |
157 | Dementia (HP:0000726) | 1.83825192 |
158 | Polyneuropathy (HP:0001271) | 1.82803052 |
159 | Cholelithiasis (HP:0001081) | 1.81612926 |
160 | Abnormality of the gallbladder (HP:0005264) | 1.81257892 |
161 | Abnormality of the lumbar spine (HP:0100712) | 1.80819402 |
162 | Increased mean platelet volume (HP:0011877) | 1.79657098 |
163 | Thrombophlebitis (HP:0004418) | 1.79084689 |
164 | Hypertensive crisis (HP:0100735) | 1.78699113 |
165 | Pulmonary infiltrates (HP:0002113) | 1.78587053 |
166 | Enlarged kidneys (HP:0000105) | 1.78276342 |
167 | Abnormality of the periventricular white matter (HP:0002518) | 1.78110887 |
168 | Abnormality of the Achilles tendon (HP:0005109) | 1.77752087 |
169 | Back pain (HP:0003418) | 1.77730849 |
170 | Menorrhagia (HP:0000132) | 1.76808734 |
171 | Renal cortical cysts (HP:0000803) | 1.75714154 |
172 | Opisthotonus (HP:0002179) | 1.75333362 |
173 | Malnutrition (HP:0004395) | 1.73700979 |
174 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.73407647 |
175 | Hyperparathyroidism (HP:0000843) | 1.72461726 |
176 | Pseudobulbar signs (HP:0002200) | 1.72228456 |
177 | Gout (HP:0001997) | 1.71770536 |
178 | Achilles tendon contracture (HP:0001771) | 1.70736371 |
179 | Obstructive lung disease (HP:0006536) | 1.70272549 |
180 | Chronic obstructive pulmonary disease (HP:0006510) | 1.70272549 |
181 | Vomiting (HP:0002013) | 1.70121450 |
182 | Vasculitis (HP:0002633) | 1.69047326 |
183 | Peritonitis (HP:0002586) | 1.65984869 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 5.52040580 |
2 | SIK1 | 5.48665216 |
3 | NME2 | 3.61726936 |
4 | TAOK2 | 3.54113302 |
5 | ERBB4 | 3.25184776 |
6 | TRIB3 | 3.15194754 |
7 | FGFR4 | 3.03464217 |
8 | PRPF4B | 2.99081629 |
9 | INSRR | 2.80114237 |
10 | PKN2 | 2.79317915 |
11 | FLT3 | 2.68832224 |
12 | ERN1 | 2.65431029 |
13 | MST1R | 2.56394046 |
14 | GRK7 | 2.54697633 |
15 | LATS1 | 2.53339129 |
16 | PIM2 | 2.52897525 |
17 | FRK | 2.29138883 |
18 | MATK | 2.14843570 |
19 | BMPR2 | 2.14375331 |
20 | TAOK3 | 2.12556415 |
21 | MET | 2.11677319 |
22 | CAMK1D | 2.10456683 |
23 | TAOK1 | 1.98207683 |
24 | RIPK4 | 1.97891600 |
25 | FGFR2 | 1.96278390 |
26 | MOS | 1.91865544 |
27 | NEK9 | 1.87507761 |
28 | IRAK4 | 1.78471698 |
29 | MAP3K11 | 1.74227509 |
30 | IRAK3 | 1.54001588 |
31 | LATS2 | 1.50445971 |
32 | BLK | 1.48231430 |
33 | MAP2K3 | 1.47164081 |
34 | CLK1 | 1.33968406 |
35 | MAP3K14 | 1.33828783 |
36 | MAPK11 | 1.32140797 |
37 | ARAF | 1.31999657 |
38 | STK38L | 1.31119181 |
39 | PBK | 1.31029671 |
40 | ICK | 1.30214239 |
41 | FGR | 1.29561364 |
42 | EPHB1 | 1.28758368 |
43 | FGFR3 | 1.28099267 |
44 | PRKAA2 | 1.24936487 |
45 | MAP3K13 | 1.17489515 |
46 | PTK6 | 1.16993229 |
47 | EPHA2 | 1.12717262 |
48 | MAP3K1 | 1.12696020 |
49 | ABL2 | 1.12614594 |
50 | BMX | 1.09456296 |
51 | EPHA3 | 1.08068069 |
52 | MAP3K5 | 1.05944417 |
53 | JAK1 | 1.03262861 |
54 | JAK2 | 1.02968980 |
55 | DDR2 | 1.02781728 |
56 | TYRO3 | 1.02237535 |
57 | GSK3A | 0.97284836 |
58 | PDGFRA | 0.96238011 |
59 | CAMK1G | 0.93856743 |
60 | STK3 | 0.93313242 |
61 | CDC42BPA | 0.92672180 |
62 | TBK1 | 0.89636112 |
63 | DYRK1B | 0.89291549 |
64 | MAP4K1 | 0.88682806 |
65 | EIF2AK3 | 0.86092730 |
66 | CDK6 | 0.84185268 |
67 | MAP3K3 | 0.83445671 |
68 | SGK494 | 0.81641684 |
69 | SGK223 | 0.81641684 |
70 | PRKAA1 | 0.81627116 |
71 | SGK3 | 0.81598302 |
72 | TYK2 | 0.81391107 |
73 | CSNK1G1 | 0.80784220 |
74 | CHUK | 0.79657337 |
75 | PINK1 | 0.78838763 |
76 | SGK2 | 0.76362461 |
77 | ERBB2 | 0.75854075 |
78 | RET | 0.75320749 |
79 | LMTK2 | 0.73916750 |
80 | CSK | 0.73862446 |
81 | RIPK1 | 0.73650100 |
82 | ZAP70 | 0.73487402 |
83 | SIK3 | 0.73090525 |
84 | DYRK3 | 0.72074628 |
85 | MAP2K4 | 0.70018217 |
86 | MAP3K2 | 0.69615135 |
87 | TGFBR2 | 0.69609007 |
88 | KSR1 | 0.68918427 |
89 | IRAK1 | 0.66944042 |
90 | BRAF | 0.64961730 |
91 | SCYL2 | 0.63994692 |
92 | MAP2K1 | 0.61737230 |
93 | FER | 0.60279578 |
94 | PRKACG | 0.59985429 |
95 | MAP3K8 | 0.58327813 |
96 | CSF1R | 0.57649682 |
97 | ADRBK2 | 0.57409853 |
98 | PRKCZ | 0.57226485 |
99 | PIK3CG | 0.56872523 |
100 | IGF1R | 0.56160520 |
101 | IRAK2 | 0.55989725 |
102 | EEF2K | 0.54942600 |
103 | CAMKK2 | 0.52677679 |
104 | MARK3 | 0.52481744 |
105 | PTK2 | 0.52440163 |
106 | STK10 | 0.50825892 |
107 | STK24 | 0.50296602 |
108 | PRKG2 | 0.49556601 |
109 | TESK1 | 0.48042441 |
110 | MAPK4 | 0.47445848 |
111 | PDGFRB | 0.47444137 |
112 | CDK14 | 0.47432967 |
113 | TXK | 0.46747641 |
114 | LYN | 0.46470912 |
115 | RAF1 | 0.46304310 |
116 | TRPM7 | 0.45870160 |
117 | JAK3 | 0.45692658 |
118 | TESK2 | 0.45260907 |
119 | IKBKB | 0.43680133 |
120 | CDK15 | 0.43276690 |
121 | IKBKE | 0.42994340 |
122 | MAP3K9 | 0.42842543 |
123 | EIF2AK2 | 0.42354157 |
124 | MAPK15 | 0.42250870 |
125 | SYK | 0.42129038 |
126 | RPS6KB1 | 0.41579832 |
127 | PAK4 | 0.40751682 |
128 | CSNK1A1L | 0.40705453 |
129 | FGFR1 | 0.40394348 |
130 | CDK11A | 0.39924646 |
131 | ABL1 | 0.39885247 |
132 | CDK18 | 0.39737644 |
133 | CDK4 | 0.39606739 |
134 | BCR | 0.38700599 |
135 | CSNK1G3 | 0.38654913 |
136 | NLK | 0.37564178 |
137 | PDPK1 | 0.37169087 |
138 | MTOR | 0.37163520 |
139 | PAK3 | 0.36367680 |
140 | PRKCH | 0.33986579 |
141 | ACVR1B | 0.33579819 |
142 | PKN1 | 0.32196668 |
143 | CSNK1G2 | 0.31811742 |
144 | MAP2K2 | 0.31317598 |
145 | RPS6KL1 | 0.30923961 |
146 | RPS6KC1 | 0.30923961 |
147 | PIM1 | 0.30800628 |
148 | MAPKAPK5 | 0.29222924 |
149 | EPHB2 | 0.27107718 |
150 | PDK2 | 0.25391684 |
151 | DAPK3 | 0.25250675 |
152 | EGFR | 0.24890433 |
153 | LCK | 0.24766857 |
154 | KSR2 | 0.22973649 |
155 | MAPK3 | 0.22965340 |
156 | HIPK2 | 0.22755460 |
157 | PDK1 | 0.22464430 |
158 | CDK12 | 0.22292347 |
159 | PRKCQ | 0.21628346 |
160 | HCK | 0.21378924 |
161 | DYRK2 | 0.20986025 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.97665851 |
2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.63252846 |
3 | Other glycan degradation_Homo sapiens_hsa00511 | 3.31238787 |
4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.17369775 |
5 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 3.07539093 |
6 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.95135155 |
7 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.64277409 |
8 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.57056659 |
9 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.55204986 |
10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.52925006 |
11 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.49793296 |
12 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.48944448 |
13 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.47525211 |
14 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.47429729 |
15 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.45367174 |
16 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.39393501 |
17 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.35250231 |
18 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.33804008 |
19 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.27333781 |
20 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.23630665 |
21 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.19777001 |
22 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.19097304 |
23 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.18768869 |
24 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.12498149 |
25 | Pertussis_Homo sapiens_hsa05133 | 2.12188878 |
26 | Peroxisome_Homo sapiens_hsa04146 | 2.08557647 |
27 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.06664191 |
28 | Leishmaniasis_Homo sapiens_hsa05140 | 1.99769022 |
29 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.95944707 |
30 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.94991545 |
31 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.89647746 |
32 | Salmonella infection_Homo sapiens_hsa05132 | 1.80966102 |
33 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.79348922 |
34 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.75720985 |
35 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.75508720 |
36 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.75108388 |
37 | Histidine metabolism_Homo sapiens_hsa00340 | 1.74005563 |
38 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.71573037 |
39 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.66676130 |
40 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.63914059 |
41 | Tuberculosis_Homo sapiens_hsa05152 | 1.61773134 |
42 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.60873236 |
43 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.59853684 |
44 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.59209475 |
45 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.57978488 |
46 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.57857973 |
47 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.56290289 |
48 | Retinol metabolism_Homo sapiens_hsa00830 | 1.55790414 |
49 | Influenza A_Homo sapiens_hsa05164 | 1.55374049 |
50 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.54373779 |
51 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.53287521 |
52 | Asthma_Homo sapiens_hsa05310 | 1.49932466 |
53 | Allograft rejection_Homo sapiens_hsa05330 | 1.39639563 |
54 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.38217171 |
55 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.37987150 |
56 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.35281773 |
57 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.32292119 |
58 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.32191992 |
59 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.31898408 |
60 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.31729987 |
61 | Bile secretion_Homo sapiens_hsa04976 | 1.31602637 |
62 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.29806547 |
63 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.29670472 |
64 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.25780810 |
65 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.24781167 |
66 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.22833728 |
67 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.22075363 |
68 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.16766807 |
69 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.16053396 |
70 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.14568305 |
71 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.12678685 |
72 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.11588458 |
73 | Hepatitis B_Homo sapiens_hsa05161 | 1.09888364 |
74 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.08998596 |
75 | ABC transporters_Homo sapiens_hsa02010 | 1.06573445 |
76 | Shigellosis_Homo sapiens_hsa05131 | 1.04680762 |
77 | Measles_Homo sapiens_hsa05162 | 1.03950125 |
78 | Carbon metabolism_Homo sapiens_hsa01200 | 1.03665184 |
79 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.03632502 |
80 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.03252712 |
81 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.03230324 |
82 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.01856950 |
83 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.00262507 |
84 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.94944171 |
85 | Phagosome_Homo sapiens_hsa04145 | 0.94322594 |
86 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.92704848 |
87 | Sulfur relay system_Homo sapiens_hsa04122 | 0.89547975 |
88 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.89395610 |
89 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.88436616 |
90 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.88377226 |
91 | Apoptosis_Homo sapiens_hsa04210 | 0.88041329 |
92 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.87667670 |
93 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.84610781 |
94 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.84384841 |
95 | Amoebiasis_Homo sapiens_hsa05146 | 0.84374384 |
96 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.82669964 |
97 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.81982246 |
98 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.81281270 |
99 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.80636352 |
100 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.77824598 |
101 | Lysine degradation_Homo sapiens_hsa00310 | 0.75999160 |
102 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.73489346 |
103 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.73450194 |
104 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.69081729 |
105 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.68443022 |
106 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.65777111 |
107 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.64533173 |
108 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.64064095 |
109 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.61971921 |
110 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.61918849 |
111 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.59771365 |
112 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.58537016 |
113 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.56484402 |
114 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.56289807 |
115 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.55862084 |
116 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.55006125 |
117 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.53766123 |
118 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.53447142 |
119 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.48470148 |
120 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.45295130 |
121 | Prion diseases_Homo sapiens_hsa05020 | 0.44887017 |
122 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.44615543 |
123 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.44539662 |
124 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.44170227 |
125 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.42601792 |
126 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.42188057 |
127 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.41572537 |
128 | Metabolic pathways_Homo sapiens_hsa01100 | 0.40974727 |
129 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.39257789 |
130 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.39199021 |
131 | Galactose metabolism_Homo sapiens_hsa00052 | 0.38302037 |
132 | Viral myocarditis_Homo sapiens_hsa05416 | 0.37674989 |
133 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.37143460 |
134 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.36654801 |
135 | Insulin resistance_Homo sapiens_hsa04931 | 0.35863695 |
136 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.24813898 |
137 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.23853666 |
138 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.22202815 |
139 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.20298282 |
140 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.17274337 |
141 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.14785754 |
142 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.09803086 |
143 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.08830900 |
144 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.06532118 |
145 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.04674475 |
146 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.04164995 |
147 | Lysosome_Homo sapiens_hsa04142 | 0.03129210 |
148 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.01536723 |
149 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.1531892 |
150 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1505834 |
151 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1383330 |
152 | Prolactin signaling pathway_Homo sapiens_hsa04917 | -0.1311176 |
153 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.1255184 |
154 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1242539 |
155 | Bladder cancer_Homo sapiens_hsa05219 | -0.1092771 |
156 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0859784 |
157 | Protein export_Homo sapiens_hsa03060 | -0.0676236 |
158 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.0620453 |
159 | Legionellosis_Homo sapiens_hsa05134 | -0.0567936 |
160 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.0565809 |
161 | Hepatitis C_Homo sapiens_hsa05160 | -0.0533905 |
162 | Malaria_Homo sapiens_hsa05144 | -0.0273341 |